Published by Duncan Ferris on 6th July 2018
(Sharecast News) - Biogen's shares soared on Friday after the company announced that one of the experimental Alzheimer's drugs it had developed with Japan's Eisai had succeeded in a mid-stage clinical trial.
URL: http://www.digitallook.com/dl/news/story/27703063/...